Evaluating the Impact of Introducing Basaglar, a Long-acting Analog Insulin, on Clinical and Quality of Life Outcomes in Youth with Diabetes in Bangladesh

NCT06674135 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
202
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Life for a Child Program, Diabetes Australia

Collaborators